MACHINE NAME = WEB 2

High-level dialogue on investment in life sciences and healthcare

Default Image
AR
Meeting Date
9 September 2026
10:00 - 11:30 hrs. Xiamen International Expo Centre
Location
Xiamen, China
Body

Agenda focus

Driven by demographic changes, technological advances and the transformation of healthcare systems, the life sciences and healthcare sector is emerging as one of the most strategically important sectors globally, for both governments and investors. Europe and China possess strong complementary advantages in life sciences research, industrial ecosystems and market scale, offering expanding opportunities for cooperation and long-term investment collaboration.

This forum will bring together investors, life sciences companies and innovation platforms from China and Europe to explore frameworks for cross-border investment cooperation, pathways for industrialization and commercialization, and collaboration in the life sciences sector. The dialogue aims to promote the development of a sustainable China–Europe investment cooperation network in life sciences and healthcare that benefits society globally.

Speakers

  • Assaf Barnea, Founder and Chief Executive Officer, Sanara Ventures
  • Elina Drakvik, Senior Lead & Project Lead, Finnish Innovation Fund Sitra
  • Ping Li, Vice President, Greater China, BD (Becton Dickinson)
  • Roman Plewka, Co-CEO, Formo Foods GmbH
  • Diana Saraceni, General Partner, Panakes Partners
  • Bing Xie, Senior Vice Chairman, Charoen Pokphand Group; Chairman, CP Pharmaceutical Group
  • Dechao Yu, Founder, Chairman and Chief Executive Officer, Innovent Biologics

languages
Language(s)
English | 简体中文